Name | 4-chloro-N,N,6-trimethylpyrimidin-2-amine |
---|---|
Synonyms |
4-dimethylamino-2-chloro-6-methylpyrimidine
4-Chloro-N,N,6-trimethyl-2-pyrimidinamine 4-Chloro-2-dimethylamino-6-methylpyrimidin 4-chloro-2-dimethylamino-6-methylpyrimidine (4-chloro-6-methyl-pyrimidin-2-yl)-dimethyl-amine (4-Chlor-6-methyl-pyrimidin-2-yl)-dimethyl-amin EINECS 227-243-7 |
Density | 1.207g/cm3 |
---|---|
Boiling Point | 272.1ºC at 760mmHg |
Melting Point | 35-36ºC |
Molecular Formula | C7H10ClN3 |
Molecular Weight | 171.62700 |
Flash Point | 118.4ºC |
Exact Mass | 171.05600 |
PSA | 29.02000 |
LogP | 1.50440 |
Index of Refraction | 1.567 |
HS Code | 2933599090 |
---|
~% 5734-62-3 |
Literature: TAISHO PHARMACEUTICAL CO., LTD.; Arena Pharmaceuticals, Inc Patent: WO2005/95357 A2, 2005 ; Location in patent: Page/Page column 137; 138 ; WO 2005/095357 A2 |
HS Code | 2933599090 |
---|---|
Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |